---
schema_version: '1.0'
id: news-20260825-c61359
title: 生華科CX-5461完成Phase 1b收案 明年首季出爐CSR、拚全球授權
url: https://www.ctee.com.tw/news/20260825701277-430504
url_hash: c613599774011921ae7946098427b20cdb088ef053df8ac3611bf39dbe6563b6
canonical_url: https://www.ctee.com.tw/news/20260825701277-430504
source: bing
category: news/science
category_raw: science
region: JP
tags:
- science
- 工商時報
lang: ja
published_at: '2026-08-24T17:50:00Z'
fetched_at: '2026-08-25T10:46:34.121325Z'
updated_at: '2026-08-25T10:51:09Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- BING / science
- CSR
- CX-5461
- Phase
- science
entities_en:
- name: BING / science
  type: organization
topics_en:
- science
numeric_facts: []
entities:
- name: BING / science
  type: organization
key_facts: []
related: []
related_auto: []
computed_at: '2026-08-25T10:51:01Z'
---

# 生華科CX-5461完成Phase 1b收案 明年首季出爐CSR、拚全球授權

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- science / 工商時報

## Details
(本文なし。リンク先参照)

## Source
元記事: [生華科CX-5461完成Phase 1b收案 明年首季出爐CSR、拚全球授權](https://www.ctee.com.tw/news/20260825701277-430504) — published 2026-08-24T17:50:00Z